Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
JBIO · NASDAQ · Pharmaceutical Preparations
Jade Biosciences (JBIO) · oqro.io/stocks/JBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$16.14+0.27 (+1.70%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Next results expected Mar 4, 2027, after the market closes (Q4 2026). Dates can move until the company confirms them.
No coverage found
Nothing that names this company in the last three weeks, or the news service did not answer.
Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.
15 current reports (Form 8-K), 3 on a weighty item (executive change, acquisition, restructuring, debt, auditor, listing). The date is the event's own date when the filing states one. Each line says what kind of event was reported, from the SEC item numbers; for the weightiest ones the company's own first sentence is quoted as filed. Every line links to the filing.
